New York Uni Medical Center

New York, New York 10016

0 studies enrolling now · 2 studies all time

What they study most

Diffuse Large B-Cell Lymphoma, Lymphoma Follicular, Lymphocytic Leukemia, Chronic, Lymphoma, Non Hodgkin

Studies at this site

• A Safety, Efficacy and Pharmacokinetic Study of BTCT4465A (Mosunetuzumab) as a Single Agent and Combined With Atezolizumab in Non-Hodgkin's Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL) — Completed
• A Study of Atezolizumab in Combination With Either Obinutuzumab Plus Bendamustine or Obinutuzumab Plus (+) Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (CHOP) in Participants With Follicular Lymphoma (FL) or Rituximab + CHOP in Participants With Diffuse Large B-Cell Lymphoma (DLBCL) — Completed